Webcasts & Presentations
Upcoming Events
| Date | Event Details | Remind me |
|---|---|---|
|
November 2, 2023 at 9:00 AM EDT
|
Q3 2023 Earnings Call
|
|
|
December 12, 2023 at 9:00 AM EST
|
2024 Guidance Call
|
|
|
February 6, 2024
|
Q4 2023 Earnings Call
|
|
|
April 30, 2024
|
Q1 2024 Earnings Call
|
|
|
August 8, 2024
|
Q2 2024 Earnings Call
|
|
|
October 30, 2024
|
Q3 2024 Earnings Call
|
Archived Events
| Date | Event Details |
|---|---|
|
September 11, 2023 at 2:55 PM EDT
|
Morgan Stanley 21st Annual Global Healthcare Conference
Speaker: Dr. Dan Skovronsky, Executive Vice President, Chief Scientific and Medical Officer, and President of Lilly Research Laboratories
|
|
August 8, 2023 at 9:00 AM EDT
|
Q2 2023 Earnings Call
Q2 2023 Lilly Press Release 304.6 KB
Q2 2023 Lilly Presentation 10.2 MB
|
|
July 17, 2023 at 1:30 PM EDT
|
2023 AAIC Lilly Alzheimer’s Disease Update
|
|
July 17, 2023 at 10:15 AM EDT
|
Alzheimer's Association International Conference Scientific Presentation - Donanemab TRAILBLAZER-ALZ 2
|
|
June 12, 2023 at 4:20 PM EDT
|
Goldman Sachs 44th Annual Global Healthcare Conference
Speaker: Anat Ashkenazi, Executive Vice President and Chief Financial Officer
|
|
May 10, 2023 at 1:00 PM EDT
|
Bank of America Securities 2023 Healthcare Conference
Speaker: Patrik Jonsson, Senior Vice President, President of Lilly Immunology and Lilly USA, and Chief Customer Officer
|
|
April 27, 2023 at 10:00 AM EDT
|
Q1 2023 Earnings Call
Q1 2023 Lilly Press Release 254.7 KB
Q1 2023 Lilly Presentation 7.9 MB
Q1 2023 Financial Workbook 98.2 KB
|
|
March 6, 2023 at 1:30 PM EST
|
Cowen's 43rd Annual Health Care Conference
Speaker: Mike Mason, Executive Vice President and President, Lilly Diabetes and Obesity
|
|
February 16, 2023 at 12:00 PM EST
|
SVB Securities Global Biopharma Conference
Speaker: Ilya Yuffa, Executive Vice President and President, Lilly International
|
|
February 9, 2023 at 10:10 AM EST
|
Guggenheim Oncology Conference
Speakers: Jake Van Naarden, Executive Vice President and CEO, Loxo@Lilly and David Hyman, M.D., Chief Medical Officer, Loxo@Lilly
|
|
February 2, 2023 at 10:00 AM EST
|
Q4 2022 Earnings Call
Q4 2022 Lilly Press Release 312.3 KB
Q4 2022 Lilly Presentation 12.4 MB
Q4 2022 Financial Workbook 107.5 KB
|
|
January 10, 2023 at 3:45 PM PST
|
41st Annual J.P. Morgan Healthcare Conference
Speaker: Dave Ricks, Chair and Chief Executive Officer
|
|
December 13, 2022 at 9:00 AM EST
|
2023 Guidance Call
2023 Guidance Press Release 217.4 KB
2023 Guidance Presentation 2.6 MB
|
|
November 30, 2022 at 12:10 PM EST
|
Evercore ISI HealthCONx Conference
Speakers: Jake Van Naarden, Executive Vice President and CEO of Loxo@Lilly and David Hyman, M.D., Chief Medical Officer, Loxo@Lilly
|
|
November 1, 2022 at 9:00 AM EDT
|
Q3 2022 Earnings Call
Q3 2022 Lilly Press Release 318.9 KB
Q3 2022 Lilly Presentation 12.2 MB
|
|
September 13, 2022 at 11:10 AM EDT
|
Morgan Stanley 20th Annual Global Healthcare Conference
Speaker: Anat Ashkenazi, Senior Vice President and Chief Financial Officer |
|
September 7, 2022 at 3:30 PM EDT
|
Citi’s 17th Annual BioPharma Conference
Speaker: Dr. Dan Skovronsky, Senior Vice President and Chief Scientific Officer
|
|
August 4, 2022 at 10:00 AM EDT
|
Q2 2022 Earnings Call
Q2 2022 Lilly Press Release 309 KB
Q2 2022 Lilly Presentation 11.7 MB
Q2 2022 Financial Workbook 106.1 KB
|
|
June 14, 2022 at 1:40 PM EDT
|
Goldman Sachs 43rd Annual Global Healthcare Conference
Speakers: Anne White, Senior Vice President and President, Lilly Neuroscience and Mark Mintun, Senior Vice President, R&D – Neuroscience and President, Avid Radiopharmaceuticals
|
